JOURNAL of
ONCOLOGICAL
SCIENCES

Similar Articles

  • A lung adenocarcinoma patient with EGFR mutation in exon 18 and ALKrearrangement who treated with erlotinib and crizotinib a Necmettin Erbakan University, Meram Faculty of Medicine, Department of Medical Oncology, Konya, Turkey b Necmettin Erbakan University, Meram Faculty of Medicine, Department of Nuclear Medicine, Konya, Turkey c Necmettin Erbakan University, Meram Faculty of Medicine, Department of Radiology, Konya, Turkey d Istanbul Genetics Laboratory, Istanbul, Turkey e Necmettin Erbakan University, Meram Faculty of Medicine, Department of Pathology, Konya, Turkey DOI: 10.1016/j.jons.2018.04.001 Sayfalar: 111 - 113 1607 Viewed.